Pharmacogenomics and sexuality: a vision

References

• Basson R, Wierman ME, van Lankveld J, Brotto L. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2010;7:314–26
   PubMed Web of Science ®Google Scholar
• McCabe M, Althof SE, Assalian P, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2010;7:327–36
   PubMed Web of Science ®Google Scholar
• Burri AV, Cherkas LM, Spector TD. The genetics and epidemiology of female sexual dysfunction (FSD): A review. J Sex Med 2009;6:646–57
   PubMed Web of Science ®Google Scholar
• Basson R. Recent advances in women’s sexual function and dysfunction. Menopause 2004;11:714–25
   PubMed Web of Science ®Google Scholar
• Nappi RE. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 2007;10(Suppl 2):105–8
   PubMed Web of Science ®Google Scholar
• Nappi R, Salonia A, Traish AM, et al. Clinical biologic pathophysiologies of women’s sexual dysfunction. J Sex Med 2005;2:4–25
   PubMed Web of Science ®Google Scholar
• Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet 2007;369:409–24
   PubMed Web of Science ®Google Scholar
• Basson R, Rees P, Wang R, Montejo AL, Incrocci L. Sexual function in chronic illness. J Sex Med 2010;7:374–88
   PubMed Web of Science ®Google Scholar
• Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta- analysis. J Sex Med 2012;9:1497–507
   PubMed Web of Science ®Google Scholar
• Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI-associated sexual dysfunction in women at midlife. Climacteric 2012;15:306–16
   PubMed Web of Science ®Google Scholar
• Wierman ME, Nappi RE, Avis N, et al. Endocrine aspects of women’s sexual function. J Sex Med 2010;7:561–85
   PubMed Web of Science ®Google Scholar
• Nappi RE, Polatti F. The use of estrogen therapy in women’s sexual functioning. J Sex Med 2009;6:603–16
   PubMed Web of Science ®Google Scholar
• Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990;19:389–408
   PubMed Web of Science ®Google Scholar
• Hayes RD, Bennett CM, Fairley CK, Dennerstein L. What can prevalence studies tell us about female sexual difficulty and dysfunction?J Sex Med 2006;3:589–95
   PubMed Web of Science ®Google Scholar
• Laumann EO, Paik A, Sexual Rosen RC. Dysfunction in the United States. Prevalence and predictors. JAMA 1999;281: 537–44
   PubMed Web of Science ®Google Scholar
• Nicolosi A, Laumann EO, Glasser DB, et al. Sexual behavior and sexual dysfunctions after age 40: the Global Study of Sexual Attitudes and Behaviors. Urology 2004;64:991–7
   PubMed Web of Science ®Google Scholar
• Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970–8
   PubMed Web of Science ®Google Scholar
• Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas 2009;63: 138–41
   PubMed Web of Science ®Google Scholar
• West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 2008;14:1441–9
   Google Scholar
• Leiblum SR, Koochaki PE, Rodenberg GA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46–56
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (DSM-IV-TR). Washington DC: American Psychiatric Association, 2000
   Google Scholar
• Basson R, Leiblum S, Brotto L, et al. Revised definitions of women's sexual dysfunction. J Sex Med 2004;1:24–39
   PubMed Web of Science ®Google Scholar
• Bancroft J. The medicalization of female sexual dysfunction: the need for caution. Arch Sex Behav 2002;3:451–5
   Google Scholar
• Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women’s sexual desire and arousal disorders. J Sex Med 2010;7:586–614
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425–7
   PubMed Web of Science ®Google Scholar
• Sobecki JN, Curlin FA, Rasinski KA, Lindau ST. What we don’t talk about when we don’t talk about sex: results of a national survey of US obstetrician/gynecologists. J Sex Med 2012;9: 1285–94
   PubMed Web of Science ®Google Scholar
• Pfaff DW. Brain Arousal and Information Theory: Neural and Genetic Mechanisms. Cambridge, Mass: Harvard University Press, 2006
   Google Scholar
• Pfaff D, Frohlich J, Morgan M. Hormonal and genetic influences on arousal – sexual and otherwise. Trends Neurosci 2002;25: 45–50
   PubMed Web of Science ®Google Scholar
• Majdic G, Tobet S. Cooperation of sex chromosomal genes and endocrine influences for hypothalamic sexual differentiation. Front Neuroendocrinol 2011;32:137–45
   PubMed Web of Science ®Google Scholar
• Schober JM, Pfaff D. The neurophysiology of sexual arousal. Best Pract Res Clin Endocrinol Metab 2007;21:445–61
   PubMed Web of Science ®Google Scholar
• McDevitt MA, Glidewell-Kenney C, Jimenez MA, et al. New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice. Mol Cell Endocrinol 2008;290:24–30
   PubMed Web of Science ®Google Scholar
• Traish AM, Botchevar E, Kim NN. Biochemical factors modulating female genital sexual arousal physiology. J Sex Med 2010; 7:2925–46
   PubMed Web of Science ®Google Scholar
• Burri A. Bringing sex research into the 21st century: genetic and epigenetic approaches on female sexual function. J Sex Res 2013; 50:318–28
   PubMed Web of Science ®Google Scholar
• Burnett AL, Goldstein I, Andersson KE, et al. Future sexual medicine physiological treatment targets. J Sex Med 2010;7: 3269–304
   PubMed Web of Science ®Google Scholar
• Burri, A, Cherkas, L, Spector T. The genetic epidemiology of female sexual dysfunction: A review. J Sex Med 2009;6: 646–57
   PubMed Web of Science ®Google Scholar
• Witting K, Santilla P, Rijsdijk F, et al. Correlated genetic and non-shared environmental influences account for the comorbidity between female sexual dysfunctions. Psychol Med 2009;26: 1–13
   Google Scholar
• Dawood K, Kirk KM, Bailey JM, Andrews PW, Martin NG. Genetic and environmental influences of the frequency of orgasm in women. Twin Res Hum Genet 2005;8:27–33
   PubMed Web of Science ®Google Scholar
• Dunn KM, Cherkas LF, Spector TD. Genetics of variation in female orgasmic function; a twin study. Biol Lett 2005;22: 260–3
   Web of Science ®Google Scholar
• Hettema JM, Neale MC, Kendler KS. A review and meta- analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatr 2001;158:1568–15
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatr 2000;157:1552–15
   PubMed Web of Science ®Google Scholar
• Jang K, Wesley WJ, Vemon PA. Heritability of the big five personality dimensions and their facets: a twin study. J Pers 1996; 64:577–591
   PubMed Web of Science ®Google Scholar
• Burri A, Greven C, Leupin M, Spector T, Rahman Q. A multivariate twin study of female sexual dysfunction. J Sex Med 2012;9:2671–81
   PubMed Web of Science ®Google Scholar
• Clayton AH, Groth J. Etiology of female sexual dysfunction. Womens Health 2013;9:135–7
   Google Scholar
• Burri A, Rahman Q, Spector T. Genetic and environmental risk factors for sexual distress and its association with female sexual dysfunction. Psychol Med 2011;41:2435–45
   PubMed Web of Science ®Google Scholar
• Burri A, Spector T, Rahman Q. The etiological relationship between anxiety sensitivity, sexual distress, and female sexual dysfunction is partly genetically moderated. J Sex Med 2012; 9:1887–96
   PubMed Web of Science ®Google Scholar
• Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506–33
   PubMed Web of Science ®Google Scholar
• Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH. Serotonin 2A-1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology 2006;31:2281–8
   PubMed Web of Science ®Google Scholar
• Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology 2009;34: 1819–28
   PubMed Web of Science ®Google Scholar
• Ben Zion IZ, Tessler R, Cohen L, et al. Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function. Mol Psychiatry 2006;11:782–6
   PubMed Web of Science ®Google Scholar
• Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011;8:15–27
   PubMed Web of Science ®Google Scholar
• Norbury TA, MacGregor AJ, Urwin J, Spector TD, McMahon SB. Heritability of responses to painful stimuli in women: a classical twin study. Brain 2007;13:27–42
   Google Scholar
• Giraldi A, Marson L, Nappi R, et al. Physiology of female sexual function: animal models. J Sex Med 2004;1:237–53
   PubMed Web of Science ®Google Scholar
• Salonia A, Giraldi A, Chivers ML, et al. Physiology of women’s sexual function: basic knowledge and new findings. J Sex Med 2010;7:2637–60
   PubMed Web of Science ®Google Scholar
• Abdel-Hamid IA, Andersson KE. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. Pharmacogenomics 2009;10:1625–44
   PubMed Web of Science ®Google Scholar
• Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Interleukin-1beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003;107:74–7
   PubMed Web of Science ®Google Scholar
• Jeremias J, Ledger WJ, Witki SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000;182:283–5
   PubMed Web of Science ®Google Scholar
• Burri A, Hysi P, Clop A, Rahman Q, Spector TD. A genome-wide association study of female sexual dysfunction. PLoS One 2012;7:e35041
   PubMed Web of Science ®Google Scholar
• Kalow W. Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine. Pharmacogenomics J 2006;6:162–5
   PubMed Web of Science ®Google Scholar
• Shastry BS. Genetic diversity and new therapeutic concepts. J Hum Genet 2005;50:321–8
   PubMed Web of Science ®Google Scholar
• Elaut E, Buysse A, De Sutter P, et al. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception 2012;85:470–9
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Gallicchio L, Schilling C, et al. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol 2005;106:1372–81
   PubMed Web of Science ®Google Scholar
• Massart F. Human races and pharmacogenomics of effective bone treatments. Gynecol Endocrinol 2005;20:36–44
   PubMed Web of Science ®Google Scholar
• Rebbeck TR, Troxel AB, Norman S, et al. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk. Am J Epidemiol 2007;166:1392–9
   PubMed Web of Science ®Google Scholar
• Cooke GE. Post-menopausal hormone therapy and cardiovascular events: a new paradigm based on pharmacogenetics?Future Cardiol 2008;4:19–21
   PubMedGoogle Scholar
• Yu KD, Huang AJ, Shao ZM. Tailoring adjuvant endocrine therapy for postmenopausal breast cancer: a CYP2D6 multiple-genotype-based modeling analysis and validation. PLoS One 2010;5:e15649
   Google Scholar
• Justenhoven C, Obazee O, Brauch H. The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy. Pharmacogenomics 2012;13:659–75
   PubMed Web of Science ®Google Scholar
• Notelovitz M. Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause. Med Gen Med 2006;8:85
   PubMedGoogle Scholar
• Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57–65
   PubMed Web of Science ®Google Scholar
• Herrington DM, Howard TD. ER-alpha variants and the cardiovascular effects of hormone replacement therapy. Pharmacogenomics 2003;4:269–77
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Fujino T, Shirogane T, et al. Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 2002;4:193–201
   Google Scholar
• Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007;4:1001–8
   PubMed Web of Science ®Google Scholar
• Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI-associated sexual dysfunction in women at midlife. Climacteric 2012;15:306–16
   PubMed Web of Science ®Google Scholar
• Portman DJ, Bachmann GA, Simon JA; and the Ospemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 2013 Jan 28. Epub ahead of print
   Web of Science ®Google Scholar
• Zhang X, Allan GF, Tannenbaum P, et al. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator. J Steroid Biochem Mol Biol 2013;134:51–8
   PubMed Web of Science ®Google Scholar